A short opinion post argues that speeding up weight loss with retatrutide shouldn't come ahead of actually getting healthier.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
A roundup of where Lilly's experimental retatrutide stands in 2026. Specifics are in the full piece.
A clinician reminds patients on GLP-1 medications that their bodies are not flawed or broken. A short brand post with a body-positive message.
Loading…